Literature DB >> 3936403

Effect of pretreatment with the calcium antagonist nimodipine on local cerebral blood flow and histopathology after middle cerebral artery occlusion.

A A Mohamed, O Gotoh, D I Graham, K A Osborne, J McCulloch, A D Mendelow, G M Teasdale, A M Harper.   

Abstract

We used the [14C]iodoantipyrine autoradiography technique to study the effect of pretreatment with the calcium antagonist nimodipine on local cerebral blood flow (lCBF) in rats that underwent middle cerebral artery (MCA) occlusion. In untreated control animals there were profound localized reductions in 1CBF 30 minutes after MCA occlusion. These were most pronounced in neocortical areas and in the caudate nucleus ipsilateral to the MCA occlusion. In animals pretreated with nimodipine (1 microgram X kg-1 X min-1 for 30 minutes before and 30 minutes after MCA occlusion), the ipsilateral decrease in 1CBF in cortical regions was significantly less than that in control animals. The drug did not appear to alter 1CBF in the ipsilateral caudate nucleus. Neuropathological quantification of the ischemic damage present 3 hours after occlusion showed that nimodipine pretreatment reduced the volume and extent of cellular damage in the periphery but not in the core of the lesion.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3936403     DOI: 10.1002/ana.410180613

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  18 in total

1.  Effect of calcium antagonists on regional cerebral blood flow in transplanted rat brain tumors.

Authors:  K Matsukado; K Ikezaki; T Nomura; M Fukui
Journal:  J Neurooncol       Date:  1996-01       Impact factor: 4.130

2.  Compared effects of calcium entry blockers on calcium-induced tension in rat isolated cerebral and peripheral resistance vessels.

Authors:  G Julou-Schaeffer; J L Freslon
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-12       Impact factor: 3.000

3.  Nimodipine has no beneficial effect on neurological outcome in a cardiopulmonary arrest model in the rat.

Authors:  P A Calle; M G Bogaert; L De Ridder; W A Buylaert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-06       Impact factor: 3.000

Review 4.  Experimental animal models and inflammatory cellular changes in cerebral ischemic and hemorrhagic stroke.

Authors:  Tao Yan; Michael Chopp; Jieli Chen
Journal:  Neurosci Bull       Date:  2015-12-02       Impact factor: 5.203

Review 5.  Nimodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cerebrovascular disease.

Authors:  M S Langley; E M Sorkin
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

6.  Experimental intracerebral haemorrhage: the effect of nimodipine pretreatment.

Authors:  E J Sinar; A D Mendelow; D I Graham; G M Teasdale
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-05       Impact factor: 10.154

7.  Effects of emopamil on postischemic blood flow and neuronal damage in rat brain.

Authors:  G W Bielenberg; D Sauer; J Nuglisch; T Beck; C Rossberg; H D Mennel; J Krieglstein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989 Jan-Feb       Impact factor: 3.000

8.  Pretreatment with a competitive NMDA antagonist D-CPPene attenuates focal cerebral infarction and brain swelling in awake rats.

Authors:  C K Park; J McCulloch; J K Kang; C R Choi
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

9.  Quantitative assessment of early brain damage in a rat model of focal cerebral ischaemia.

Authors:  K A Osborne; T Shigeno; A M Balarsky; I Ford; J McCulloch; G M Teasdale; D I Graham
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-04       Impact factor: 10.154

10.  Nimodipine does not affect the flow-metabolism couple in permanent cerebral ischemia.

Authors:  Shintaro Gomi; Mark G Burnett; Andrea Karp; Joel H Greenberg
Journal:  Exp Brain Res       Date:  2004-01-30       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.